[Barriers to implementing screening, brief intervention and referral to treatment for substance use in HIV/AIDS health services in Peru].
Screening and treatment for substance use among people living with HIV/AIDS (PLWHA) is highly recommended. Nevertheless, in Peru healthcare for PLWHA does not include a standardized or systematic assessment to identify substance use. The aim of this study was to assess the feasibility of implementing screening, brief intervention and referral to treatment (SBIRT) in healthcare settings attending people living with PLWHA.
After providing training in SBIRT for PLWHA's healthcare personnel (including nurses and physicians) focus groups were conducted to explore knowledge, beliefs and perceived barriers to implementation and interviews were conducted to assess the barriers and facilitators of two tertiary hospitals in Lima, Peru.
focus groups and interviews' thematic coding revealed three dimensions: 1) the unknown extent of substance use within PLWHA, 2) space and time limitations hinder completion of brief interventions during routine visits, and 3) insufficient access to substance use treatment appropriate for HIV patients.
Multiple barriers, including lack of awareness of substance use problems, limited space and time of providers, and lack of specialized services to refer patients for treatment make it difficult to implement SBIRT in the Peruvian healthcare system.
International Center for Advanced Research and Applied Science - INCAAS, Lima-Perú.|School of Public Health & Preventive Medicine, Oregon Health & Science University, Portland Oregon. EE. UU.
Kim A
KA
Hoffman
Unidad de Análisis y Generación de Evidencias en Salud Pública, Centro Nacional de Salud Pública, Instituto Nacional de Salud. Lima, Perú.
Jessica
J
Beltrán
International Center for Advanced Research and Applied Science - INCAAS, Lima-Perú.|The George Washington University, Milken Institute School of Public Health and Health Services. EE. UU.
Javier
J
Ponce
Estrategia Sanitaria Nacional de Prevención y Control de ITS VIH/SIDA, Ministerio de Salud del Perú. Lima, Perú.
Lisset
L
García-Fernandez
Hospital Nacional Cayetano Heredia. Lima, Perú.
María
M
Calderón
School of Public Health & Preventive Medicine, Oregon Health & Science University, Portland Oregon. EE. UU.
John
J
Muench
Unidad de Análisis y Generación de Evidencias en Salud Pública, Centro Nacional de Salud Pública, Instituto Nacional de Salud. Lima, Perú.
Carlos
C
Benites
Hospital Nacional Cayetano Heredia. Lima, Perú.
Leslie
L
Soto
School of Public Health & Preventive Medicine, Oregon Health & Science University, Portland Oregon. EE. UU.
Dennis
D
McCarty
Instituto de Evaluación de Tecnologías en Salud e Investigación, Seguro Social de Salud. Lima, Perú.
Fabián
F
Fiestas
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D015658:HIV Infections; D006297:Health Services Accessibility; D006801:Humans; D010568:Peru; D012017:Referral and Consultation; D019966:Substance-Related Disorders / Q000628:therapy*